Philippe Pouletty MD Overview
- Company
- EVEXTA BIO
- Primary Position
-
Co-Founder & Boa...
- Primary Industry
-
Healthcare
- Active Board Seats
-
10
- Med. Deal Size
-
- Med. Valuation
-
Philippe Pouletty MD General Information
Biography
Dr. Philippe Pouletty is a Co-Founder and serves as Board Member at EVEXTA BIO. Dr. Pouletty co-founded and served as Chairman at Skinosive. He serves as a President & Board Member at PK MED. He served as Chairman and President at SpikImm. He is a Co-Founder and serves as Chief Executive Officer at Truffle Capital. He serves as a Board Member at Cellaïon. He is also a Co-Founder and serves as President and Chairman at Caranx Medical. He is also a Co-Founder and serves as a Board Member at Deinove. He served as a Board Member at Biokinésis. He is a Co-Founder and serves as Chairman at Nanosive. He Co-founded and served as a Board Member at Pharnext. He served as a Board Member of Dementia. Previously, he served as a Member of the Supervisory Board at Innate Pharma. He is a pioneer in the biotechnologies and medical devices sector with experience in both France and Silicon Valley. He is the Founder and Chairman of Deinove (Alternext: ALDEI), Co-founder and Board member of Carbios (Alternext: ALCRB), Carmat (Alternext: ALCAR), Vexim (Alternext: ALVXM), Board member of Myopowers, Kephalios, Symetis, Theraclion (Alternext: ALTHE), Theradiag (Alternext: ALTER) and Altimmune, all of which are Truffle Capital portfolio companies. He is an independent board member of Innate Pharma (Euronext). Before co-founding Truffle, He founded SangStat (1988, therapeutic for organ transplants, listed on NASDAQ in 1993, sold to Genzyme for USD 600M in 2002), and Conjuchem (founded in 1993, listed on the Toronto Stock Exchange in 2000). He is also the former Chairman (2001-2009) and current Honorary Chairman of France Biotech, the French biotech industry association, and former Vice Chairman of EuropaBio, the European biotech industry association. He conceived the Young Innovative Enterprise Status (JEI), which was implemented in France by President Chirac in 2004. He is the inventor of 29 patents, including the second-highest revenue-generating life science patent for Stanford University, earning him entry into the prestigious Stanford University Hall of Fame of Inventors in 2012. He was also awarded the Chevalier of the Légion d'Honneur. Educational qualifications: A former hematology and immunology resident in Parisian hospitals, He holds an MD from the University of Paris VI and a Master's in immunology and virology from l'Institut Pasteur, was a post-doctoral research fellow (1986-1988) at Stanford University, and the 1999 laureate of the American Liver Foundation.
Contact Information
Address
- 104 Boulevard de Sébastopol
- 75003 Paris
- France
Philippe Pouletty MD Positions (5)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Caranx Medical | Company | Co-Founder, President and Chairman | Paris, France | Surgical Devices | |
EVEXTA BIO | Company | Co-Founder & Board Member | Paris, France | Drug Discovery | |
PK MED | Company | President & Board Member | Paris, France | Drug Discovery | |
SpikImm | Company | Chairman & President | Paris, France | Biotechnology | |
Truffle Capital | Investor | Co-Founder & Chief Executive Officer | Paris, France | Venture Capital |
Philippe Pouletty MD Board Seats (11)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Abivax | Biotechnology | Publicly Held | Formerly PE-Backed | Paris, France | |
Affluent Medical | Therapeutic Devices | Publicly Held | Formerly PE-Backed | Aix-en-Provence, France | |
Caranx Medical | Surgical Devices | Privately Held (backing) | Private Equity-Backed | Paris, France | |
Carbios | Environmental Services (B2B) | Publicly Held | Formerly PE-Backed | Clermont-Ferrand, France | |
Carmat | Therapeutic Devices | Publicly Held | Formerly PE-Backed | Velizy Villacoublay, France |
Philippe Pouletty MD Lead Partner on Deals (41)
Philippe Pouletty MD has been the lead partner on 41 deals. Their latest deal was with Cellaïon, a drug discovery company. The deal was made on 18-Jan-2023.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Cellaïon | 18-Jan-2023 | Later Stage VC | Completed | Drug Discovery | Mont-Saint-Guibert, Belgium | |
Abivax | 02-Sep-2022 | Completed | Biotechnology | Paris, France | ||
Holistick Medical | 05-Apr-2021 | Completed | Other Devices and Supplies | Paris, France | ||
Carbios | 25-Jun-2019 | Completed | Environmental Services (B2B) | Clermont-Ferrand, France | ||
PK MED | 01-Jan-2019 | Completed | Drug Discovery | Paris, France | ||
Skinosive | 09-Oct-2018 | Completed | Other Healthcare Technology Systems | Paris, France | ||
Altimmune | 08-Oct-2018 | Completed | Drug Discovery | Gaithersburg, MD | ||
Holistick Medical | 19-Dec-2017 | Completed | Other Devices and Supplies | Paris, France | ||
Carmat | 08-Dec-2017 | PIPE | Completed | Therapeutic Devices | Velizy Villacoublay, France | |
Carmat | 07-Jul-2017 | Secondary Transaction - Open Market | Completed | Therapeutic Devices | Velizy Villacoublay, France |
Philippe Pouletty MD Network (398)
Board Members (201)
Name | Company | Representing | Location | From |
---|---|---|---|---|
William Enright | Altimmune | Self | Gaithersburg, MD | |
Jose Da Gloria | Affluent Medical | Self | Aix-en-Provence, France | |
Altimmune | Altimmune | Gaithersburg, MD | ||
Neovacs | Self | Suresnes, France | ||
Carmat | Self | Velizy Villacoublay, France |
Portfolio Executives (183)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
René Mignolet Ph.D | Cellaïon | Vice President, Regulatory Affairs | 18-Jan-2023 | Mont-Saint-Guibert, Belgium |
Eddy Rommel Ph.D | Cellaïon | Vice President, Preclinical Development | 18-Jan-2023 | Mont-Saint-Guibert, Belgium |
Cellaïon | President | 18-Jan-2023 | Mont-Saint-Guibert, Belgium | |
Cellaïon | Vice President, Regulatory Affairs | 18-Jan-2023 | Mont-Saint-Guibert, Belgium | |
Cellaïon | Chief Financial Officer & General Manager | 18-Jan-2023 | Mont-Saint-Guibert, Belgium |
Fund Team Members (14)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Benjamin Rieder | Truffle Capital | Truffle Financial Innovation Fund | Paris, France |
Claire Corot | Truffle Capital | Truffle Medeor Fund | Paris, France |
Truffle Capital | Paris, France | ||
Truffle Capital | Paris, France | ||
Truffle Capital | Paris, France |
Philippe Pouletty MD Affiliated Funds (11)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Truffle BioMedTech Crossover Fund | Truffle Capital | Buyout | Closed | 2019 | ||||
Truffle Financial Innovation Fund | Truffle Capital | Venture - General | Closed | 2019 | ||||
Truffle Capital II | Truffle Capital | Venture - General | Closed | 2008 | ||||
UFF Innovation 5 | Truffle Capital | Venture - General | Liquidated | 2005 | ||||
UFF Innovation 8 | Truffle Capital | Venture - General | Liquidated | 2010 |
Philippe Pouletty MD FAQs
-
Who is Philippe Pouletty MD?
Dr. Philippe Pouletty is a Co-Founder and serves as Board Member at EVEXTA BIO.
-
How much does Philippe Pouletty MD typically invest?
Philippe Pouletty MD's median deal size is
. -
What is Philippe Pouletty MD’s main position?
Philippe Pouletty MD’s primary position is Co-Founder & Board Member.
-
What are the contact details for Philippe Pouletty MD?
Philippe Pouletty MD’s email address is ph
and his phone number is +33 01 . -
How many active board seats does Philippe Pouletty MD hold?
Philippe Pouletty MD holds 11 board seats including Abivax, Affluent Medical, Caranx Medical, Carbios, and Carmat.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »